Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28939836 | 0.86 | CYP1A2 (0.42) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL31515156 | 0.86 | CYP1A2 (0.42) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL16244634 | 0.82 | KIF11 (0.32) | KIF11CYP1A2 | |
| SCHEMBL28415409 | 0.81 | NR1I2 (0.31) | — | |
| SCHEMBL28522288 | 0.81 | CYP1A2 (0.41) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL133411 | 0.81 | CYP1A2 (0.39) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL29818226 | 0.79 | ALDH1A1 (0.41) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL22534075 | 0.79 | ALDH1A1 (0.41) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL925882 | 0.79 | CYP1A2 (0.42) | KIF11ERBB2CYP1A2FYNMAOA | |
| SCHEMBL515458 | 0.79 | ALDH1A1 (0.41) | KIF11ERBB2CYP1A2FYNMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
| EP-3028320-A1 | ELECTRO-OPTICAL DEVICE AND USE THEREOF | Merck Patent GmbH (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-2688646-A1 | ORGANIC IONIC FUNCTIONAL MATERIALS | Merck Patent GmbH (DE) | 2014-01-29 | — | — | EP | disclosed |
| EP-2545600-A2 | RADIATIVE FIBERS | Merck Patent GmbH (DE) | 2013-01-16 | — | — | EP | disclosed |
| WO-2012126566-A1 | ORGANIC IONIC FUNCTIONAL MATERIALS | MERCK PATENT GMBH (DE) | 2012-09-27 | — | — | WO | disclosed |
| WO-2011110275-A2 | RADIATIVE FIBERS | MERCK PATENT GMBH (DE) | 2011-09-15 | — | — | WO | disclosed |
| US-7649211-B2 | Organic light emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | CYP1A1, CYP1A2, XPOT | KIF11 4103/4885ERBB2 3373/4885CYP1A2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.